查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947279

智慧仿生宠物市场（按动物类型、技术、仿生技术和最终用户划分），全球预测，2026-2032年

Intelligent Bionic Pet Market by Animal Type, Technology, Bionics Technology, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，智慧仿生宠物市场价值将达到 2.8547 亿美元，到 2026 年将成长至 3.3161 亿美元，到 2032 年将达到 8.8547 亿美元，复合年增长率为 17.55%。

关键市场统计数据
基准年 2025 2.8547亿美元
预计年份：2026年 3.3161亿美元
预测年份 2032 8.8547亿美元
复合年增长率 (%) 17.55%

为智慧仿生宠物领域建立清晰的框架，整合技术进步、与兽医学的合作以及商业性应用趋势。

智慧仿生宠物领域融合了兽医学、机器人技术和宠物消费护理，重新定义了动物福利、行动能力和感官功能的理念。轻型致动器、紧凑型电源系统和微型感测器的发展，正为行动不便、感官障碍或需要特殊服务的宠物带来实际的解决方案。随着产品原型逐渐成熟并最终走向商业化，从兽医诊所到专业零售商等各方相关人员都在探索一个不断发展的设备认证、临床检验和用户采纳生态系统。

技术、临床、监管和分销趋势的汇合正在重新定义智慧仿生宠物领域的产品开发和应用。

智慧仿生宠物领域正经历多个转折点，这些转折点正在改变产品的开发、检验和上市方式。感测器小型化和机器学习技术的进步使得设备能够适应个别动物的行为，从而提升舒适度和功能效果。同时，工程师和兽医专业人员之间的跨学科合作提高了临床证据和人性化设计的标准，使设备更容易被专业人士和宠物饲主接受。

为因应智慧仿生宠物价值链中累积的关税压力，各企业正采取策略性因应措施，重塑供应商选择、製造地和定价策略。

关税政策和贸易措施将对智慧仿生宠物产业的製造商和经销商的供应链、采购和定价策略产生重大影响。近期关税调整迫使企业重新评估其供应商基础，实现零件采购多元化，并考虑将生产外包或在地化生产，以降低跨境成本波动的风险。这些策略转变通常需要重新评估库存管理，调整与供应商的合约条款，并投入资金在靠近关键市场的地方建立替代生产线。

透过对动物种类、设备技术、通路、最终用户和价格点进行综合分析，建构一个精细的市场区隔模型，从而为产品设计和市场推广策略提供切实可行的建议。

深入的細項分析揭示了动物类型、仿生技术、分销管道、终端用户和价格点的哪些组合正在驱动不同的需求和采用模式。对猫和狗的物种差异检验，可以发现它们在人体工学和行为设计方面有显着差异。猫分为室内猫、室外猫和宠物猫三类，通常需要轻巧灵活的外形和隐藏的安装系统以保持灵活性。而狗则分为宠物狗、服务犬和工作犬三类，它们通常需要高承重能力、柔软性和特定任务的介面。

区域趋势和营运需求决定了产品在美洲、欧洲、中东和非洲以及亚太市场的相关性、临床参与度和分销策略。

区域趋势正在影响关键地区的产品优先顺序、监管方式和通路开发，为智慧仿生宠物领域的企业带来独特的机会和挑战。在美洲，消费者在宠物健康方面的强劲支出和完善的兽医服务网络推动了高端设备的普及和临床应用，而区域监管差异和物流复杂性则促使企业投资于本地伙伴关係和客製化服务项目。区域内的跨境贸易凸显了统一的品质标准和可互通的服务体系对于高效能业务拓展的重要性。

领先的製造商和服务供应商如何将技术差异化、临床检验和服务生态系统结合，打造可扩展的竞争优势

推动智慧仿生宠物市场发展的主要企业，将工程技术专长、兽医合作和可扩展的服务模式相结合，以提供差异化的价值提案。领先的创新者优先进行多学科研究和临床伙伴关係，以检验设备的安全性和有效性，并投资于以使用者为中心的设计和迭代测试，以提高动物和看护者的接受度。这些公司的策略重点领域包括：降低客製化成本的模组化硬体架构、支援远端调整的整合式远端监控解决方案，以及管理安装、维护和备件供应的持久服务生态系统。

为经营团队提供一条切实可行的实施路径，以建立具有韧性的供应链、临床证据和全通路服务模式，从而推动永续应用。

产业领导者应优先采取一系列切实可行的措施，在管控风险的同时，将策略意图转化为市场认可。首先，组成跨职能团队，整合工程、兽医学和客户体验设计等领域，以加快迭代速度，缩短以人为本和以动物为中心的产品的市场接受度。其次，实现供应链多元化，探索区域组装方案，以降低贸易中断和关税相关成本波动带来的风险，并透过严格的供应商筛选来确保产品品质。

严谨的多源调查方法，整合了原始临床数据、技术评估和二手研究，以产生可操作的、以福祉为中心的见解。

本分析的调查方法融合了定性访谈、文献综述和技术评估，旨在从技术、临床和商业三个领域对资讯进行三角验证。主要研究包括对兽医、产品设计师、復健专家和通路合作伙伴进行结构化访谈，以收集关于设备适配性、用户接受度和售后服务的第一手资讯。这些访谈揭示了实际应用中的限制因素和潜在机会，尤其是在人体工学、行为相容性和服务需求方面。

本文从福利、证据和营运成熟度三个面向，全面观点了智慧仿生解决方案永续应用的条件。

智慧仿生宠物领域正从实验性创新转向以服务为导向的实用产品，旨在改善动物福利并增强其功能。这个进程将取决于工程师、兽医、监管相关人员和商业伙伴之间的持续合作，将安全性、有效性和伦理责任融入产品生命週期。那些能够显着改善动物活动能力和感官功能，同时透过可维护的设计和灵活的分销模式，使之能够被广大终端用户所接受的解决方案，将更容易被市场接受。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依动物类型分類的智慧仿生宠物市场

  • 猫
  • 狗

9. 科技驱动的智慧仿生宠物市场

  • 仿生增强
  • 连接/智慧功能
  • 移动/驱动机构
  • 感觉功能/互动

第十章 仿生技术引领的智慧仿生宠物市场

  • 外骨骼
  • 提高行动能力
  • 感觉扩展

第十一章 智慧仿生宠物市场（以终端用户划分）

  • 消费者/家庭
  • 教育/娱乐
  • 老年护理
  • 服务/工作动物使用案例

第十二章 各区域的智慧仿生宠物市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 智慧仿生宠物市场（依群体划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国智慧仿生宠物市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国智慧仿生宠物市场

第十六章：中国的智慧仿生宠物市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ANYbotics AG
  • Bionic Pets
  • Boston Dynamics
  • DEEP Robotics
  • Ghost Robotics Corporation
  • Hiwonder
  • Intuition Robotics Ltd.
  • Petoi Technology Co., Ltd.
  • Sony Group Corporation
  • Sure Petcare Limited
  • Tombot, Inc.
  • Tomofun Ltd.
  • Unitree Robotics Co., Ltd.
  • WEILAN Co., Ltd.
  • Whistle Labs, Inc.
  • WowWee Group Limited
  • Xiaomi Inc
Product Code: MRR-4F7A6D4FB660

The Intelligent Bionic Pet Market was valued at USD 285.47 million in 2025 and is projected to grow to USD 331.61 million in 2026, with a CAGR of 17.55%, reaching USD 885.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 285.47 million
Estimated Year [2026] USD 331.61 million
Forecast Year [2032] USD 885.47 million
CAGR (%) 17.55%

A clear framing of the intelligent bionic pet landscape that synthesizes technological advances, veterinary collaboration, and commercial adoption dynamics

The Intelligent Bionic Pet sector represents a convergence of veterinary medicine, robotics, and consumer pet care that is redefining how animal welfare, mobility, and sensory capabilities are addressed. Developments in lightweight actuators, compact power systems, and miniaturized sensors have translated into practical solutions for pets with mobility impairments, sensory deficits, or specialized service roles. As product prototypes mature into commercial offerings, stakeholders from veterinary clinics to specialty retailers are navigating an evolving ecosystem of device certification, clinical validation, and user adoption.

Emerging designs prioritize animal comfort, ergonomic fit, and non-invasive interfaces, reflecting informed collaboration between engineers, veterinarians, and animal behaviorists. This interdisciplinary approach has improved acceptance rates among pets and increased owner confidence in adopting advanced assistive technologies. At the same time, supply chain innovation and digital distribution channels are changing how products are introduced to owners and professionals, enabling more tailored fitting services, telehealth-enabled follow-up, and modular upgrades that extend device utility over time.

Transitioning from concept to routine care requires attention to regulatory pathways, clinical outcomes, and ethical considerations. Stakeholders must reconcile rapid technological progress with robust safety testing and transparent efficacy evidence to build long-term trust. Consequently, decision-makers should view the Intelligent Bionic Pet opportunity as a long-term transformation of care models rather than a short-term product play.

How converging technological, clinical, regulatory, and distribution trends are redefining product development and adoption in the intelligent bionic pet sector

Several transformative shifts are reshaping the Intelligent Bionic Pet landscape, altering how products are developed, validated, and brought to market. Advances in sensor miniaturization and machine learning have enabled devices that adapt behaviorally to individual animals, improving comfort and functional outcomes. Concurrently, cross-disciplinary partnerships between engineers and veterinary clinicians have elevated the standard for clinical evidence and humane design, making devices more acceptable to both professionals and pet owners.

Supply chain resilience and modular manufacturing approaches have reduced lead times for specialized components, while the rise of direct-to-consumer and hybrid distribution models has expanded routes to end users beyond traditional clinical channels. Regulatory frameworks are also adapting; while standards continue to vary across jurisdictions, there is a notable trend toward clearer guidance on animal-assistive devices, fostering greater investment in clinical trials and post-market surveillance. Ethical considerations around animal welfare, user consent, and data privacy are attracting attention from advocacy groups and professional bodies, prompting manufacturers to embed transparency and traceability into product lifecycles.

Taken together, these shifts are creating a more credible, scalable ecosystem for intelligent bionic applications in animals, where sustained adoption will hinge on measurable outcomes, cost-effective servicing models, and collaborative stakeholder engagement.

Strategic responses to cumulative tariff pressures that reshape supplier sourcing, manufacturing footprints, and pricing strategies across the intelligent bionic pet value chain

Tariff policies and trade measures can materially influence supply chains, component sourcing, and pricing strategies for manufacturers and distributors operating in the Intelligent Bionic Pet space. Recent tariff adjustments have prompted companies to reassess supplier footprints, diversify component sourcing, and consider nearshoring or regional manufacturing to mitigate exposure to cross-border cost volatility. These strategic shifts often require recalibration of inventory management, contractual terms with suppliers, and capital allocation to set up alternate production lines closer to key markets.

In response, procurement teams are prioritizing supplier resilience and dual-sourcing arrangements for critical components such as actuators, battery modules, and specialized sensors. Companies that previously relied on single-source overseas suppliers are now exploring partnerships with regional manufacturers and contract assemblers to reduce tariff-related margin pressures. These operational changes also affect aftersales service networks, spare parts logistics, and warranty planning, necessitating tighter integration between manufacturing and customer service teams.

From a commercial perspective, pricing strategies must account for tariff-induced cost differentials while remaining competitive and accessible to end users. Manufacturers that proactively restructure supply chains to absorb tariff impacts through efficiency gains, redesigns for component standardization, or localized assembly stand a better chance of preserving margins and maintaining market momentum. Ultimately, understanding the cumulative implications of tariff changes is essential for leadership teams planning capital investment, partner selection, and long-term distribution strategies.

Nuanced segmentation analysis that connects animal types, device technologies, channels, end users, and price tiers to actionable design and go-to-market implications

Insightful segmentation illuminates which combinations of animal types, bionics technologies, distribution channels, end users, and price ranges are driving differentiated requirements and adoption patterns. Examining animal type distinctions among cats and dogs reveals divergent ergonomic and behavioral design imperatives; cats, differentiated into indoor cats, outdoor cats, and pet cats, typically demand lighter, more flexible form factors and unobtrusive attachment systems to preserve agility, whereas dogs, segmented into pet dogs, service dogs, and working dogs, often require higher load capacity, ruggedization, and task-specific interfaces.

Bionics technology delineations between exoskeletons, mobility enhancement, and sensory augmentation indicate varied engineering priorities. Mobility enhancement subdivides into joint actuators and limb prosthetics, each with distinct biomechanical control challenges and fitting workflows, while sensory augmentation breaks into auditory sensors, olfactory sensors, and visual sensors, which impose different signal processing, power, and feedback requirements. Distribution channels spanning online retail, specialty stores, and veterinary clinics create contrasting customer touchpoints; online channels emphasize digital education, remote fitting support, and convenient replenishment, specialty stores provide hands-on demonstrations and personalized fittings, and veterinary clinics integrate clinical assessment, prescription-like workflows, and post-procedural follow-up.

End users categorized as household, professional, and research reflect demand drivers that range from quality-of-life enhancements for pet owners to performance and certification requirements for service or working animals, and experimental validation needs for research institutions. Price range segmentation into high, low, and mid tiers underscores the trade-offs between advanced capabilities, custom fitting services, and accessibility. Understanding the interplay of these segments enables more precise product design, channel strategies, and service models that address the specific expectations and constraints of each cohort.

Regional dynamics and operational imperatives that determine product-fit, clinical engagement, and distribution strategies across Americas, EMEA, and Asia-Pacific markets

Regional dynamics shape product prioritization, regulatory approaches, and channel development across key geographies, yielding distinct opportunities and constraints for companies in the intelligent bionic pet space. In the Americas, strong consumer spending on pet health and established veterinary networks favor adoption of premium devices and clinical integration, but regional regulatory variability and logistics complexity encourage firms to invest in local partnerships and tailored service programs. Cross-border trade within the region also highlights the importance of harmonized quality standards and interoperable servicing arrangements to scale efficiently.

In Europe, Middle East & Africa, diverse regulatory regimes and rising demand for animal welfare-oriented solutions coexist with a cautious reimbursement environment, prompting manufacturers to emphasize clinical evidence and cost-effectiveness. Fragmented markets within the region necessitate adaptable distribution models, strong relationships with veterinary associations, and region-specific training for fitting specialists. Cultural differences in pet ownership and use of working animals further influence product form factors and communication strategies.

Asia-Pacific presents a mix of rapid urban pet ownership growth, increasing spending on premium pet products, and a dynamic manufacturing ecosystem that can support component sourcing and local assembly. Market entrants here benefit from partnerships with established veterinary networks and specialty retailers, while also navigating heterogeneous regulatory landscapes across countries. Across all regions, companies that align product design, evidence generation, and service delivery with local expectations and regulatory requirements will be better positioned to convert interest into sustained adoption.

How leading manufacturers and service providers combine technical differentiation, clinical validation, and service ecosystems to establish scalable competitive advantage

Key companies shaping the Intelligent Bionic Pet landscape combine engineering expertise, veterinary collaboration, and scalable service models to deliver differentiated value propositions. Leading innovators prioritize interdisciplinary research and clinical partnerships to validate device safety and efficacy, investing in user-centric design and iterative testing to improve acceptance among animals and caretakers. Strategic focus areas for these companies include modular hardware architectures that lower customization costs, integrated telemonitoring solutions to support remote adjustments, and durable service ecosystems to manage fittings, maintenance, and spare parts availability.

Competitive positioning often rests on intellectual property around actuator miniaturization, adaptive control algorithms, and sensor fusion techniques that enable naturalistic movement and reliable environmental sensing. At the same time, successful firms pay close attention to commercial execution, building relationships with veterinary networks, specialty retailers, and rehabilitation centers to create trusted referral pathways. Partnerships with research institutions and human-medical device suppliers can accelerate component innovation while also raising standards for clinical validation. Ultimately, companies that align technical differentiation with robust go-to-market systems and service capabilities will lead in establishing repeatable, scalable adoption among pet owners and professionals.

Actionable implementation pathways for executives to build resilient supply chains, clinical evidence, and omnichannel service models that drive sustainable adoption

Industry leaders should prioritize a set of pragmatic actions to convert strategic intent into market traction while managing risk. First, embed cross-functional teams that pair engineering, veterinary science, and customer experience design to accelerate human-animal-centered product iterations and reduce time-to-acceptance. Second, diversify supply chains and explore regional assembly options to reduce exposure to trade disruptions and tariff-related cost variability, while preserving manufacturing quality through rigorous supplier qualification.

Third, invest in clinical evidence generation and transparent outcome reporting to build trust with veterinarians, pet owners, and regulators; these data can also support premium positioning and informed reimbursement discussions. Fourth, develop flexible distribution models that combine online education and remote fitting services with in-person clinical and specialty retail touchpoints to meet distinct customer preferences. Fifth, design serviceable, modular products that simplify maintenance, enable upgrades, and lower total cost of ownership for end users. Finally, actively engage with professional associations, animal welfare organizations, and ethical review bodies to shape responsible use standards, data governance practices, and post-market surveillance frameworks that protect animal welfare and brand reputation.

Collectively, these actions create a resilient foundation for sustainable growth, balancing innovation velocity with the operational and ethical rigor required to win trust across stakeholders.

A rigorous multi-source methodology synthesizing primary clinical input, technical assessments, and secondary research to produce practical, welfare-focused insights

The research methodology underpinning this analysis integrates primary qualitative interviews, secondary literature review, and technology assessment to triangulate insights across technical, clinical, and commercial domains. Primary engagements included structured interviews with veterinary clinicians, product designers, rehabilitation specialists, and channel partners to capture firsthand experience with device fitting, user acceptance, and aftercare logistics. These conversations informed real-world constraints and opportunity areas, particularly around ergonomics, behavioral compatibility, and servicing requirements.

Secondary sources encompassed peer-reviewed veterinary and biomedical engineering literature, patent landscape scans, product technical specifications, and industry thought leadership to validate technological trajectories and identify engineering trade-offs. Technology assessments focused on actuator technologies, sensor modalities, power management approaches, and control algorithms to understand capability ceilings and integration complexity. Throughout the methodology, attention was given to ethical considerations and animal welfare standards, ensuring that recommended design and commercialization approaches align with accepted care principles.

Synthesis prioritized convergent themes across data sources, emphasizing replicable findings such as the importance of interdisciplinary design, the operational impact of supply chain shifts, and the need for robust clinical validation. This layered approach enabled the development of actionable recommendations that are grounded in practical experience and technical feasibility.

Summative perspective on the conditions for enduring adoption of intelligent bionic solutions centered on welfare, evidence, and operational maturity

The Intelligent Bionic Pet domain is transitioning from experimental innovation toward practical, service-oriented offerings that enhance animal welfare and extend functional capability. Progress hinges on sustained collaboration among engineers, veterinarians, regulatory stakeholders, and commercial partners to embed safety, efficacy, and ethical stewardship into product lifecycles. Adoption will favor solutions that deliver measurable improvements in mobility or sensory function while remaining affordable to a broad spectrum of end users through serviceable designs and adaptable distribution models.

Leaders that combine technical excellence with operational resilience and clear evidence of benefit will set the standard for long-term value creation. Regulatory clarity, regional market adaptation, and strong aftercare ecosystems are each critical to converting early interest into routine clinical and consumer practice. As the field matures, the companies that balance humane design, robust validation, and scalable servicing will define the norms for how intelligent bionic solutions are integrated into everyday care for companion and working animals alike.

In sum, the opportunity is substantial but conditional: success depends on rigorous attention to animal welfare, pragmatic supply chain strategies, and the generation of trusted clinical evidence to underpin sustainable adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intelligent Bionic Pet Market, by Animal Type

  • 8.1. Cats
  • 8.2. Dogs

9. Intelligent Bionic Pet Market, by Technology

  • 9.1. Bionic Enhancements
  • 9.2. Connectivity / Smart Features
  • 9.3. Mobility / Actuation
  • 9.4. Sensory / Interaction

10. Intelligent Bionic Pet Market, by Bionics Technology

  • 10.1. Exoskeleton
  • 10.2. Mobility Enhancement
  • 10.3. Sensory Augmentation

11. Intelligent Bionic Pet Market, by End-User

  • 11.1. Consumer/Home Use
  • 11.2. Educational / Entertainment
  • 11.3. Senior Care
  • 11.4. Service / Working Animal Use-Case

12. Intelligent Bionic Pet Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intelligent Bionic Pet Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intelligent Bionic Pet Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Intelligent Bionic Pet Market

16. China Intelligent Bionic Pet Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. ANYbotics AG
  • 17.6. Bionic Pets
  • 17.7. Boston Dynamics
  • 17.8. DEEP Robotics
  • 17.9. Ghost Robotics Corporation
  • 17.10. Hiwonder
  • 17.11. Intuition Robotics Ltd.
  • 17.12. Petoi Technology Co., Ltd.
  • 17.13. Sony Group Corporation
  • 17.14. Sure Petcare Limited
  • 17.15. Tombot, Inc.
  • 17.16. Tomofun Ltd.
  • 17.17. Unitree Robotics Co., Ltd.
  • 17.18. WEILAN Co., Ltd.
  • 17.19. Whistle Labs, Inc.
  • 17.20. WowWee Group Limited
  • 17.21. Xiaomi Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTELLIGENT BIONIC PET MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTELLIGENT BIONIC PET MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY DOGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY DOGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY DOGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONIC ENHANCEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONIC ENHANCEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONIC ENHANCEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONNECTIVITY / SMART FEATURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONNECTIVITY / SMART FEATURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONNECTIVITY / SMART FEATURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY / ACTUATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY / ACTUATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY / ACTUATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY / INTERACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY / INTERACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY / INTERACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EXOSKELETON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EXOSKELETON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EXOSKELETON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY ENHANCEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY ENHANCEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY MOBILITY ENHANCEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY AUGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY AUGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENSORY AUGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONSUMER/HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONSUMER/HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY CONSUMER/HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EDUCATIONAL / ENTERTAINMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EDUCATIONAL / ENTERTAINMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY EDUCATIONAL / ENTERTAINMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENIOR CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENIOR CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SENIOR CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SERVICE / WORKING ANIMAL USE-CASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SERVICE / WORKING ANIMAL USE-CASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY SERVICE / WORKING ANIMAL USE-CASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 92. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 102. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 107. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 112. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTELLIGENT BIONIC PET MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 123. CHINA INTELLIGENT BIONIC PET MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. CHINA INTELLIGENT BIONIC PET MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. CHINA INTELLIGENT BIONIC PET MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA INTELLIGENT BIONIC PET MARKET SIZE, BY BIONICS TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA INTELLIGENT BIONIC PET MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)